Clinical data | |
---|---|
Other names | 5-spiro-(2'-ethyl-3'-5'-dimethyl-cyclopentyl)barbituric acid |
ATC code |
|
Identifiers | |
| |
CAS Number |
|
UNII |
|
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C12H18N2O3 |
Molar mass | 238.287 g·mol−1 |
3D model (JSmol) | |
| |
(verify) |
Spirobarbital is a barbiturate derivative developed by Eli Lilly in the 1940s.[1] It has hypnotic and sedative effects, and has a moderate potential for abuse.[2]
Alcohols | |
---|---|
Barbiturates |
|
Benzodiazepines |
|
Carbamates | |
Flavonoids |
|
Imidazoles | |
Kava constituents |
|
Monoureides |
|
Neuroactive steroids |
|
Nonbenzodiazepines | |
Phenols | |
Piperidinediones | |
Pyrazolopyridines | |
Quinazolinones | |
Volatiles/gases |
|
Others/unsorted |
|